Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $2.72 Million - $2.98 Million
-12,300 Reduced 55.16%
10,000 $2.41 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $2.43 Million - $2.66 Million
-10,800 Reduced 32.63%
22,300 $5.21 Million
Q1 2024

May 15, 2024

SELL
$233.45 - $247.73 $4.2 Million - $4.46 Million
-18,000 Reduced 35.23%
33,100 $8.19 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $8.99 Million - $10.3 Million
-38,700 Reduced 43.1%
51,100 $12.5 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $7.65 Million - $8.51 Million
30,000 Added 50.17%
89,800 $23.2 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $14.3 Million - $15.9 Million
59,800 New
59,800 $15.8 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $21,740 - $24,608
100 Added 100.0%
200 $50,000
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $20,605 - $24,817
100 New
100 $25,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.